1. The potential of multi-compound nanoparticles to bypass drug resistance in cancer
   C. G. Da Silva et al, 2017, Cancer Chemother Pharmacol CrossRef
2. Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells
   Anamar M. Nassir et al, 2018, Saudi Pharmaceutical Journal CrossRef
3. The application of bio-nanotechnology in tumor diagnosis and treatment: a view
   Jingyuan Li et al, 2018 CrossRef
4. Closing the Loop: Constraining TAT Peptide by γPNA Hairpin for Enhanced Cellular Delivery of Biomolecules
   Xiaohong Tan et al, 2018, Bioconjugate Chem. CrossRef
5. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles
   Kandasamy Saravanakumar et al, 2019, Archives of Biochemistry and Biophysics CrossRef
6. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein
   Vimratjeet Kaur et al, 2014, Journal of Drug Targeting CrossRef
7. The critical role of bisphosphonates to target bone cancer metastasis: an overview
   Tejinder Singh et al, 2015, Journal of Drug Targeting CrossRef
8. TPGS2k/PLGA Nanoparticles for Overcoming Multidrug Resistance by Interfering Mitochondria of Human Alveolar Adenocarcinoma Cells
   Dong-Fang Wang et al, 2015, ACS Appl. Mater. Interfaces CrossRef
9. Combinatorial prospects of nano-targeted chemoimmunotherapy
   C.G. Da Silva et al, 2016, Biomaterials CrossRef
10. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
    Ewelina Piktel et al, 2016, J Nanobiotechnol CrossRef
11. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy
    Jafar Mosafer et al, 2017, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
12. MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers
    Manu S. Singh et al, 2017, Pharmacological Research CrossRef
13. Function of gold nanoparticles in oral cancer beyond drug delivery: Implications in cell apoptosis.
    Iman Talaat, 0 CrossRef
14. Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells
    Yusuf Haggag et al, 2020, Expert Opinion on Drug Delivery CrossRef
15. Applying Box–Behnken Design for Formulation and Optimization of PLGA-Coffee Nanoparticles and Detecting Enhanced Antioxidant and Anticancer Activities
    Nouran S. Sharaf et al, 2021, Polymers CrossRef
16. Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
    Mohamed Haider et al, 2022, IJMS CrossRef
17. Bixa orellana L. carotenoids: antiproliferative activity on human lung cancer, breast cancer, and cervical cancer cells in vitro
    Lia Kusmita et al, 2022, Natural Product Research CrossRef
18. Amphiphilic pluronic F68 biomaterial augmented oral bioavailability and anticancer activity of genistein in lung cancer treatment
    Harihar Narayan et al, 2024, Polymers for Advanced Techs CrossRef